The emergence of nosocomial infections by multidrug-resistant sequence type 117 (ST117) Enterococcus faecium has been reported in several European countries. ST117 has been detected in Spanish hospitals as one of the main causes of bloodstream infections. We analyzed genome variations of ST117 strains isolated in Madrid and describe the first ST117 closed genome sequences.
A recent worldwide increase in multidrug-resistant (MDR) Enterococcus faecium strains that cause infections in hospitals has been associated with the abrupt emergence of E. faecium populations belonging to the lineage 78. Among this lineage, isolates identified as sequence type 117 (ST117) are predominantly recovered in many European health institutions (1-6). In Spain, ST117 E. faecium isolates are increasingly identified from clinical isolates and have been identified as causing bloodstream infections (BSIs) since 2006 (7) .
We report here the sequences of five ST117 E. faecium isolates belonging to an endemic clone causing bacteremia and frequently colonizing hospitalized patients in our hospital, mostly at the gastroenterology (30.1%) and hematology (16.4%) wards (5, 7) . All isolates were resistant to ampicillin, erythromycin, ciprofloxacin, and levofloxacin and, eventually, resistant to high levels of streptomycin, gentamicin, and tetracycline. Comparative genomics between these five ST117 genome sequences and others available at the GenBank database will help elucidate possible factors that might have contributed to the emergence of particular clones.
Five ST117 isolates associated with bloodstream (n ϭ 4) and urinary tract (n ϭ 1) infections were selected for this study based on their antibiotic susceptibilities, virulence/colonization traits, and origin (community and hospital) (5, 7). DNA extraction was performed with the Wizard genomic DNA purification kit (Promega, Madison, WI). DNA concentration was measured with a NanoDrop 2000 (Thermo Scientific) and Qubit 2.0 fluorometer (Life Technologies, Inc.). All strains were sequenced using Illumina (2 ϫ 101-bp, 900ϫ coverage), with one of them also being sequenced by PacBio (800ϫ coverage) in order to close the first genome of this pandemic lineage. The Illumina reads and Illumina plus PacBio reads were assembled using SPAdes 3.5.0 (8) and RS_HGAP_Assembly.2 (9). Genome annotation was performed using PGAAP from NCBI (10) at the GenBank submission step.
The genome of the E. faecium ST117 E1 strain has a circular chromosome with 2,925,525 bp and a GϩC content of 38.0%, 2,862 coding sequences (CDS), 71 tRNAs, and six rRNA operons. E1 strain harbors four circular plasmids ranging from 3,296 bp to 230,049 bp: pE1_230 (230,049 bp), pE1_29 (29,012 bp), pE1_13 (13,112 bp), and pE1_3 (3,199 bp) .
The PacBio assembly yields a genome of significant larger size than that obtained by using Illumina. The "genome gain" mainly corresponded to transposases, insertion sequences, and RNA operon copies that were probably collapsed during the Illumina assembly process. Thus, our results reflect the suitability of PacBio for fully characterizing plasmids and virulence islands of enterococci, which are chimeric elements that are impossible to elucidate by using other next-generation sequencing (NGS) approaches (6, 11) . The more closely related strains were ST117 strains isolated in our hospital (Ͻ12 SNPs). The overall characteristics of the E1 genome were similar to those of another closed genome of the ST78 lineage (strain AUS0085) (12) . Further studies of comparative genomics studies are needed in order to understand the emergence of the ST78 lineage in the hospital setting. Accession number(s). The GenBank genome accession numbers are CP018065 to CP018069 (E1), MPZY00000000 (E2), MPZZ00000000 (E3), MQAA00000000 (E4), MQAB00000000 (E5), and MQAC00000000 (E6).
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